New drug cocktail aims to control aggressive lung cancer
Disease control
Recruiting now
This study tests a combination of two drugs, monalizumab and durvalumab, plus chemotherapy for people with small cell lung cancer. The goal is to see if this mix can keep the cancer from growing longer than standard treatment. About 84 adults with either extensive or limited stag…
Phase: PHASE2 • Sponsor: Hirva Mamdani • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC